Fig. 1From: Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of adviceRisk management - Comparison of documented lifestyle-related advice for time periods before and after release of guidelinesBack to article page